A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor

被引:275
作者
Gu, BJ
Zhang, WY
Worthington, RA
Sluyter, R
Dao-Ung, P
Petrou, S
Barden, JA
Wiley, JS
机构
[1] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia
[2] Univ Sydney, Dept Anat & Histol, Sydney, NSW 2006, Australia
[3] Univ Melbourne, Dept Physiol, Melbourne, Vic 3050, Australia
关键词
D O I
10.1074/jbc.M010353200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P2X(7) receptor is a ligand-gated cation-selective channel that mediates ATP-induced apoptosis of cells of the immune system. We and others have shown that P2X(7) is nonfunctional both in lymphocytes and monocytes from some subjects. To study a possible genetic basis we sequenced DNA coding for the carboxyl-terminal tail of P2X(7). In 9 of 45 normal subjects a heterozygous nucleotide substitution (1513A-->C) was found, whereas 1 subject carried the homozygous substitution that codes for glutamic acid to alanine at amino acid position 496. Surface expression of P2X(7) on lymphocytes was not affected by this E496A polymorphism, demonstrated both by confocal microscopy and immunofluorescent staining. Monocytes and lymphocytes from the E496A homozygote subject expressed nonfunctional receptor, whereas heterozygotes showed P2X(7) function that was half that of germline P2X(7). Results of transfection experiments showed that the mutant P2X(7) receptor was nonfunctional when expressed at low receptor density but regained function at a high receptor density. This density dependence of mutant P2X(7) function was also seen on differentiation of fresh monocytes to macrophages with interferon-gamma, which up-regulated mutant P2X(7) and partially restored its function. P2X(7)-mediated apoptosis of lymphocytes was impaired in homozygous mutant P2X(7) compared with germline (8.6 versus 35.2%). The data suggest that the glutamic acid at position 496 is required for optimal assembly of the P2X(7) receptor.
引用
收藏
页码:11135 / 11142
页数:8
相关论文
共 41 条
[1]   HIV-1 infection in an individual homozygous for the CCR5 deletion allele [J].
Biti, R ;
French, RF ;
Young, J ;
Bennetts, B ;
Stewart, G ;
Liang, T .
NATURE MEDICINE, 1997, 3 (03) :252-253
[2]   Blockade of human P2X7 receptor function with a monoclonal antibody [J].
Buell, G ;
Chessell, IP ;
Michel, AD ;
Colo, G ;
Salazzo, M ;
Herren, S ;
Gretener, D ;
Grahames, C ;
Kaur, R ;
Kosco-Vilbois, MH ;
Humphrey, PPA .
BLOOD, 1998, 92 (10) :3521-3528
[3]   Effects of antagonists at the human recombinant P2X7 receptor [J].
Chessell, IP ;
Michel, AD ;
Humphrey, PPA .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (06) :1314-1320
[4]  
Chused TM, 1996, J IMMUNOL, V157, P1371
[5]   Genetic epidemiology of single-nucleotide polymorphisms [J].
Collins, A ;
Lonjou, C ;
Morton, NE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15173-15177
[6]   P2Z/P2X7 receptor-dependent apoptosis of dendritic cells [J].
Coutinho-Silva, R ;
Persechini, PM ;
Bisaggio, RD ;
Perfettini, JL ;
Neto, ACTD ;
Kanellopoulos, JM ;
Motta-Ly, I ;
Dautry-Varsat, A ;
Ojcius, DM .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 276 (05) :C1139-C1147
[7]  
ELMOATASSIM C, 1992, J BIOL CHEM, V267, P23664
[8]   Activation of the P2Z/P2X7, receptor in human lymphocytes produces a delayed permeability lesion:: Involvement of phospholipase D1 [J].
Fernando, KC ;
Gargett, CE ;
Wiley, JS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 362 (02) :197-202
[9]   P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death [J].
Ferrari, D ;
Los, M ;
Bauer, MKA ;
Vandenabeele, P ;
Wesselborg, S ;
Schulze-Osthoff, K .
FEBS LETTERS, 1999, 447 (01) :71-75
[10]   Phospholipase D activation by P-2Z-purinoceptor agonists in human lymphocytes is dependent on bivalent cation influx [J].
Gargett, CE ;
Cornish, EJ ;
Wiley, JS .
BIOCHEMICAL JOURNAL, 1996, 313 :529-535